TY - CHAP A1 - Jasmeet Chadha Singh A2 - Amy Tiersten ED1 - Oliver F. Bathe Y1 - 2012-02-01 PY - 2012 T1 - Neoadjuvant Chemotherapy in Ovarian Cancer N2 - The most significant advances in cancer therapy in recent years have involved the development of systemic therapeutics. With improvements in response rates in solid tumors, opportunities have arisen to enhance the effectiveness of surgery. Administration of systemic therapy prior to surgery - neoadjuvant chemotherapy - represents one approach by which clinicians have successfully reduced the extent of surgery and, in some instances, positively impacted on clinical outcomes. This collection of works by expert clinicians from a variety of disciplines represents an exploration of the current knowledge of the role of neoadjuvant chemotherapy in diverse tumor types. BT - Neoadjuvant Chemotherapy SP - Ch. 6 UR - https://doi.org/10.5772/24196 DO - 10.5772/24196 SN - PB - IntechOpen CY - Rijeka Y2 - 2022-05-29 ER -